JBT Marel Outlines Ambitious 2028 Financial Targets and Strategic Vision at Investor Day
JBTM sits 45% above its 52-week low of $90.08.
Summary
JBT Marel Corporation held an Investor Day, outlining a comprehensive strategic plan and setting ambitious 2028 financial targets, including significant revenue and margin growth, and robust free cash flow generation, building on its Marel acquisition.
Key Events · Corporate Governance and Compliance · JBTM
-
Investor Day Presentation
JBT Marel Corporation hosted an Investor Day on March 26, 2026, presenting a comprehensive strategic and financial outlook to investors and market professionals.
-
Ambitious 2028 Financial Targets
The company set 2028 goals including an organic revenue CAGR of 5-7%, an Adjusted EBITDA Margin of 20% (up from 15.8% in 2025), and double-digit Return on Invested Capital (ROIC).
-
Strong Free Cash Flow Generation
JBT Marel projects generating over $1 billion in cumulative free cash flow between 2026 and 2028, with a target conversion rate of 55-60% of Adjusted EBITDA.
-
Marel Acquisition Synergy Update
The company is on track to achieve $150 million in annual run-rate cost synergy savings by the end of 2027, building on the $85 million achieved by the end of 2025. Revenue synergies are expected to contribute approximately 1% to the revenue CAGR from 2025-2028.
Analysis · JBTM · Technology
The Investor Day presentation provides a detailed roadmap for JBT Marel Corporation's future, emphasizing its strategy to become a global food technology leader. Key highlights include ambitious 2028 financial targets for organic revenue growth (5-7% CAGR), adjusted EBITDA margin (20%), and cumulative free cash flow (over $1 billion). The company also detailed significant progress on synergy realization from the Marel acquisition, with cost savings expected to reach $150 million by 2027. This comprehensive outlook, following a reported net loss in 2025, offers investors a clear vision for future profitability and shareholder value creation, making it a critical update for assessing the company's long-term potential.
At the time of this filing, JBTM was trading at $131.00 on NYSE in the Technology sector, with a market capitalization of approximately $6.8B. The 52-week trading range was $90.08 to $170.19. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.